4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028226
Options or other derivatives
- Chief Executive Officer returned 2,385,976 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
SETH SANDESH · Chief Executive Officer
Table II: Derivative
8 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-31 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −16,666 | 0 | D |
| 2025-03-31 | Returned to the company : show line 2 in the form Stock Option (Right to Buy) | −25,000 | 0 | D |
| 2025-03-31 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −33,333 | 0 | D |
| 2025-03-31 | Returned to the company : show line 4 in the form Stock Option (Right to Buy) | −50,000 | 0 | D |
| 2025-03-31 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −139,062 | 0 | D |
| 2025-03-31 | Returned to the company : show line 6 in the form Stock Option (Right to Buy) | −310,182 | 0 | D |
| 2025-03-31 | Returned to the company : show line 7 in the form Stock Option (Right to Buy) | −827,366 | 0 | D |
| 2025-03-31 | Returned to the company : show line 8 in the form Stock Option (Right to Buy) | −984,367 | 0 | D |
Loading xslF345X05/ownership.xml…